Calculation of the Tender Price and Issue Price

Investment Company PLC
19 July 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE "UNITED STATES"), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN THE INVESTMENT COMPANY PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF THE INVESTMENT COMPANY PLC.

 

The information contained within this announcement is considered by The Investment Company plc to constitute inside information pursuant to Article 7 of EU Regulation No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.


19 July 2023

The Investment Company plc

(the "Company")

LEI: 2138004PBWN5WM2XST62

NAV Update

and

Calculation of the Tender Price and Issue Price

Further to its announcement on 18 July 2023, the Company confirms that the Net Asset Value ("NAV") per Ordinary Share (including unaudited revenue but excluding any accrued Transaction Costs) at the Calculation Date, being 6.00 p.m. on 18 July 2023, was 348.38 pence per Ordinary Share. Accordingly, the Tender Price and Issue Price, which have been calculated using the methodology set out in Part 6 of the Prospectus published by the Company on 9 June 2023, are as follows:

 

TENDER PRICE:

337.76 PENCE

ISSUE PRICE:

348.38 PENCE

 

The Tender Price represents a 3.0 per cent. discount to the Company's NAV per Ordinary Share at close of business on 18 July 2023, reflecting the proportion of the Transaction Costs which will be borne by Existing Shareholders, and is equal to the estimated Post-Transaction NAV per Ordinary Share.

The Issue Price represents a 3.1 per cent. premium to the Tender Price and the estimated Post-Transaction NAV per Ordinary Share reflecting the proportion of the estimated Transaction Costs borne by Incoming Shareholders.

Directors' Participation in the Issue

The following Directors, and the Proposed Director, have subscribed for New Ordinary Shares pursuant to the Issue (the "Directors' Participation") as outlined below:

 


Existing number of Ordinary Shares held

Number of New Ordinary Shares subscribed for pursuant to the Issue

Resulting number of Ordinary Shares held

Percentage of issued share capital held on Admission

Ian Dighé

30,820

7,176

37,996

2.07%

Martin Perrin*

21,695

10,046

31,741

1.73%

David Horner

-

28,704

28,704

1.57%

*Together with his persons closely associated

 


 

Smaller Related Party Transaction

By virtue of Ian Dighé and Martin Perrin's positions as current directors of the Company, the Directors' Participation is considered to be a related party transaction for the purposes of Listing Rules. In addition, David Horner is considered to be an associate of the Proposed Manager as a result of his holding of over 30% of the shares in the Proposed Manager. The Transaction constitutes a smaller related party transaction and falls within Listing Rule 11.1.10R and this announcement is therefore made in accordance with Listing Rule 11.1.10R(2)(c). Accordingly, the Company has received written confirmation from the Sponsor that the terms of the Transaction are fair and reasonable as far as Shareholders of the Company are concerned.

Board Changes

Conditional on, and with effect from, Completion of the Tender Offer, which is expected to be on 26 July 2023, Michael Weeks has resigned from the Board and David Horner has been appointed as a non-independent non-executive Director of the Company. Further details concerning David's appointment are contained within Part 10 of the Prospectus.

 

Cancellation of the Share Premium Account and Capital Redemption Reserve

The Board further announces that the Court confirmed the cancellation of the Company's share premium account and capital redemption reserve on 18 July 2023, which was approved by Shareholders at the General Meeting on 26 June 2023, creating further distributable reserves to fund the Tender Offer.

Total Voting Rights

As announced on 18 July 2023, 3,980,664 Ordinary Shares were validly tendered pursuant to the Tender Offer, constituting 83.4 per cent. of the existing issued share capital. All validly tendered Ordinary Shares will be accepted in full with 3,747,673 Ordinary Shares repurchased by the Company and 232,991 Ordinary Shares sold to Incoming Shareholders pursuant to the Matched Bargain Facility.

 

In addition, the Company will issue 812,829 new Ordinary Shares ("New Ordinary Shares") in connection with the Offer for Subscription and Intermediaries Offer. Applications have been made for the New Ordinary Shares to be admitted to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). It is expected that Admission will become effective and that dealings will commence on or around 8.00 a.m. on 26 July 2023.

 

Following Completion of the Tender Offer and Admission, the total number of voting rights of the Company will be 1,837,205 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules with effect from Completion of the Tender Offer.

 

Any capitalised terms used but not otherwise defined in this announcement have the meaning set out in the Prospectus published by the Company in connection with the Issue.

 

Expected Timetable


2023

Repurchase of Ordinary Shares pursuant to the Tender Offer and issue of Ordinary Shares pursuant to the Issue

 

26 July

 

Admission and dealings in new Ordinary Shares commence

 

8.00 a.m. on 26 July

 

CREST accounts credited with uncertificated Ordinary Shares in respect of the Issue

 

26 July

Where applicable, definitive Ordinary Share certificates in respect of the Ordinary Shares issued pursuant to the Issue despatched by post in the week commencing*

 

31 July

* Underlying Applicants who apply to Intermediaries for Ordinary Shares under the Intermediaries Offer will not receive Ordinary Share certificates.



The dates and times specified in the timetable above are subject to change without further notice. All references to times in this announcement are to London time unless otherwise stated. Any changes to the expected Issue timetable will be notified by the Company through a Regulatory Information Service.

Enquiries

The Investment Company
Ian Dighé, Chairman


+44 (0) 20 3934 6630
info@theinvestmentcompanyplc.co.uk

 


Singer Capital Markets - Corporate Broker

+44 (0)20 7496 3000

James Moat / Alex Bond / James Fischer


 


ISCA Administration Services Limited

Company Secretary

+44 (0) 1392 487056

 

IMPORTANT NOTICE

This announcement does not constitute or form part of an offer or invitation, or a solicitation of any offer or invitation, to purchase any Ordinary Shares or other securities.

 

The full terms and conditions of the Tender Offer are set out in the Circular and the Issue are set out in the Prospectus.

 

Each of Singer Capital Markets Advisory LLP (the "Sponsor") and Singer Capital Markets Securities Limited ("SCM Securities") is authorised and regulated in the United Kingdom by the FCA. References in this document to "Singer Capital Markets" are references to either the Sponsor or SCM Securities or both of them, as appropriate. Singer Capital Markets is acting exclusively for the Company and for no-one else in connection with the matters described in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to the clients of Singer Capital Markets, nor for providing advice in relation to any of the matters referred to in this announcement.

 

None of the Company, the Proposed Manager, Singer Capital Markets, or any of their respective affiliates, accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connection therewith. The Company, the Proposed Manager, Singer Capital Markets, and their respective affiliates, accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement or its contents or otherwise arising in connection therewith.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100